Company / Current Liabilities per Share
Theravance Biopharma, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.77
FY2025
5-year range
$0.38 / $0.91
FY2021-FY2025
Trend
+16.0%
vs FY2024
Sector context
#126 of 210
Health Care
What the data says
At $0.77, Theravance Biopharma, Inc.'s current liabilities per share ranks #85 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.38 in FY2023 to $2.17 in FY2020.
Based on SEC 10-K filings.
0.77 in FY2025 with a 5-year CAGR of -18.6%.
Increased from $0.38 to $0.77 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +26.1%
- 5-Year CAGR
- -18.6%
- 10-Year CAGR
- -
Sector benchmark
-96.7% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 16.0% year-over-year.
- Ranks #126 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2020.
- Lowest current liabilities per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.77 | +16.0% |
| FY2024 | $0.67 | +75.7% |
| FY2023 | $0.38 | -1.6% |
| FY2022 | $0.39 | -57.6% |
| FY2021 | $0.91 | -58.0% |
| FY2020 | $2.17 | +8.0% |
| FY2019 | $2.01 | +10.7% |
| FY2018 | $1.81 | +53.1% |
| FY2017 | $1.18 | -8.7% |
| FY2016 | $1.30 | -15.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026